[3] On January 6, 2020, the MIT School of Engineering and Takeda, the pharmaceutical company, announced a new funding program to support research and education in AI and health.
The steering committee for the program is led by Professor Anantha P. Chandrakasan, Dean of the School of Engineering, and Anne Heatherington, senior vice president and head of Data Sciences Institute (DSI) at Takeda.
[1][7][8] On February 19, 2020, the MIT Jameel Clinic's faculty leads for AI and life sciences, Professor Regina Barzilay and Professor Jim Collins, published a paper in Cell confirming the discovery—for the first time by deep learning—of halicin, the first new antibiotic compound for 30 years, which kills over 35 powerful bacteria, including antimicrobial-resistant tuberculosis, the superbug C. difficile, and two of the World Health Organization's top-three most deadly bacteria.
[19] With a GBP 3.5m grant from Wellcome Trust, the MIT Jameel Clinic is teaming up with hospitals around the globe to bring AI into mainstream healthcare.
[22] On 25 May 2023, the MIT Jameel Clinic's faculty leads for life sciences, Jim Collins, and for AI, Regina Barzilay, and colleagues published a paper in Nature Chemical Biology announcing the deep learning-guided discover of abaucin, an antibiotic targeting Acinetobacter baumannii, one of the WHO's top-three deadliest bacteria in the world.